ID   GD149
AC   CVCL_B4UH
DR   PRIDE; PXD012308
DR   Wikidata; Q110432810
RX   PubMed=28832583;
RX   PubMed=31611696;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   HLA typing: A*01:01,24:02; B*38:01,44:03; C*06:02,12:03 (PubMed=28832583).
CC   HLA typing: DPA1*01:03,02:01; DPB1*03:01(124:01),04:01(350:01); DQA1*01:10,02:01; DQB1*02:02,06:03; DRB1*07:01,13:01; DRB3*01:01; DRB4*01:01 (PubMed=31611696).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: HLA class I peptidome analysis by proteomics.
CC   Omics: HLA class II peptidome analysis by proteomics.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
RX   PubMed=28832583; DOI=10.1371/journal.pcbi.1005725; PMCID=PMC5584980;
RA   Bassani-Sternberg M., Chong C., Guillaume P., Solleder M., Pak H.,
RA   Gannon P.O., Kandalaft L.E., Coukos G., Gfeller D.;
RT   "Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen
RT   predictions and identifies allostery regulating HLA specificity.";
RL   PLoS Comput. Biol. 13:e1005725.1-e1005725.28(2017).
//
RX   PubMed=31611696; DOI=10.1038/s41587-019-0289-6;
RA   Racle J., Michaux J., Rockinger G.A., Arnaud M., Bobisse S., Chong C.,
RA   Guillaume P., Coukos G., Harari A., Jandus C., Bassani-Sternberg M.,
RA   Gfeller D.;
RT   "Robust prediction of HLA class II epitopes by deep motif
RT   deconvolution of immunopeptidomes.";
RL   Nat. Biotechnol. 37:1283-1286(2019).
//